Inflammatory myofibroblastic tumor of the uterus: Clinical and pathologic review of 10 cases including a subset with aggressive clinical course

American Journal of Surgical Pathology

Volumn 39, Issue 2, 2015, Pages 157-168

  Parra Herran, Carlos ^a   Quick, Charles M ^b   Howitt, Brooke E ^c   Dal Cin, Paola ^c   Quade, Bradley J ^c   Nucci, Marisa R ^c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF ARKANSAS MEDICAL CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

anaplastic lymphoma kinase 1; inflammatory myofibroblastic tumor; myxoid uterine tumors

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; PROTEIN TYROSINE KINASE; TUMOR MARKER;

ADULT; AGED; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MUSCLE TUMOR; PATHOLOGY; RETROSPECTIVE STUDY; UTERUS CANCER;

ADULT; AGED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; NEOPLASMS, MUSCLE TISSUE; RECEPTOR PROTEIN-TYROSINE KINASES; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; UTERINE NEOPLASMS;

EID: 84922068307     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000330     Document Type: Review

References (34)

1. Fletcher CDM, Bridge JA, Hogendoorn P, et al. World Health Organization Classification of Tumours of Soft Tissue and Bone. Lyon, France: WHO Press; 2013.
2. Gleason BC, Hornick JL. Inflammatory myofibroblastic tumours: where are we now? J Clin Pathol. 2008;61:428-437.
3. Kovach SJ, Fischer AC, Katzman PJ, et al. Inflammatory myofibroblastic tumors. J Surg Oncol. 2006;94:385-391.
4. Mergan F, Jaubert F, Sauvat F, et al. Inflammatory myofibroblastic tumor in children: clinical review with anaplastic lymphoma kinase, Epstein-Barr virus, and human herpesvirus 8 detection analysis. J Pediatr Surg. 2005;40:1581-1586.
5. Tothova Z, Wagner AJ. Anaplastic lymphoma kinase-directed therapy in inflammatory myofibroblastic tumors. Curr Opin Oncol. 2012;24:409-413.
6. Rabban JT, Zaloudek CJ, Shekitka KM, et al. Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors. Am J Surg Pathol. 2005;29:1348-1355.
7. Gilks CB, Taylor GP, Clement PB. Inflammatory pseudotumor of the uterus. Int J Gynecol Pathol. 1987;6:275-286.
8. Kushnir CL, Gerardi M, Banet N, et al. Extrauterine inflammatory myofibroblastic tumor: a case report. Gynecol Oncol Case Rep. 2013;6:39-41.
9. Shintaku M, Fukushima A. Inflammatory myofibroblastic tumor of the uterus with prominent myxoid change. Pathol Int. 2006;56: 625-628.
10. Azuno Y, Yaga K, Suehiro Y, et al. Inflammatory myoblastic tumor of the uterus and interleukin-6. Am J Obstet Gynecol. 2003;189: 890-891.
11. Gü cer F, Altaner S, Mü layim N, et al. Invasive inflammatory pseudotumor of uterine cervix: a case report. Gynecol Oncol. 2005;98:325-328.
12. Gupta N, Mittal S, Misra R. Inflammatory pseudotumor of uterus: an unusual pelvic mass. Eur J Obstet Gynecol Reprod Biol. 2011;156:118-119.
13. Olgan S, Saatli B, Okyay RE, et al. Hysteroscopic excision of inflammatory myofibroblastic tumor of the uterus: a case report and brief review. Eur J Obstet Gynecol Reprod Biol. 2011;157:234-236.
14. Kargi HA, Ozer E, Gö kden N. Inflammatory pseudotumor of the uterus: a case report. Tumori. 1995;81:454-456.
15. Dehner LP. Inflammatory myofibroblastic tumor: the continued definition of one type of so-called inflammatory pseudotumor. Am J Surg Pathol. 2004;28:1652-1654.
16. Coffin CM, Watterson J, Priest JR, et al. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol. 1995;19:859-872.
17. Nonaka D, Birbe R, Rosai J. So-called inflammatory myofibroblastic tumour: a proliferative lesion of fibroblastic reticulum cells? Histopathology. 2005;46:604-613.
18. Coffin CM, Patel A, Perkins S, et al. ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor. Mod Pathol. 2001;14:569-576.
19. Cook JR, Dehner LP, Collins MH, et al. Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study. Am J Surg Pathol. 2001;25:1364-1371.
20. Jiang Y-H, Cheng B, Ge M-H, et al. Comparison of the clinical and immunohistochemical features, including anaplastic lymphoma kinase (ALK) and p53, in inflammatory myofibroblastic tumours. J Int Med Res. 2009;37:867-877.
21. Freeman A, Geddes N, Munson P, et al. Anaplastic lymphoma kinase (ALK 1) staining and molecular analysis in inflammatory myofibroblastic tumours of the bladder: a preliminary clinicopathological study of nine cases and review of the literature. Mod Pathol. 2004;17:765-771.
22. Sukov WR, Cheville JC, Carlson AW, et al. Utility of ALK-1 protein expression and ALK rearrangements in distinguishing inflammatory myofibroblastic tumor from malignant spindle cell lesions of the urinary bladder. Mod Pathol. 2007;20:592-603.
23. Butrynski JE, D'Adamo DR, Hornick JL, et al. Crizotinib in ALKrearranged inflammatory myofibroblastic tumor. N Engl J Med. 2010;363:1727-1733.
24. Kelleher FC, McDermott R. The emerging pathogenic and therapeutic importance of the anaplastic lymphoma kinase gene. Eur J Cancer. 2010;46:2357-2368.
25. Mossé YP, Lim MS, Voss SD, et al. Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study. Lancet Oncol. 2013;14:472-480.
26. Fuehrer NE, Keeney GL, Ketterling RP, et al. ALK-1 protein expression and ALK gene rearrangements aid in the diagnosis of inflammatory myofibroblastic tumors of the female genital tract. Arch Pathol Lab Med. 2012;136:623-626.
27. Li X-Q, Hisaoka M, Shi D-R, et al. Expression of anaplastic lymphoma kinase in soft tissue tumors: an immunohistochemical and molecular study of 249 cases. Hum Pathol. 2004;35:711-721.
28. Qiu X, Montgomery E, Sun B. Inflammatory myofibroblastic tumor and low-grade myofibroblastic sarcoma: a comparative study of clinicopathologic features and further observations on the immunohistochemical profile of myofibroblasts. Hum Pathol. 2008;39:846-856.
29. Nascimento AF, Ruiz R, Hornick JL, et al. Calcifying fibrous "pseudotumor": clinicopathologic study of 15 cases and analysis of its relationship to inflammatory myofibroblastic tumor. Int J Surg Pathol. 2002;10:189-196.
30. Cessna MH, Zhou H, Sanger WG, et al. Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases. Mod Pathol. 2002;15:931-938.
31. Coffin CM, Hornick JL, Fletcher CDM. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol. 2007;31:509-520.
32. Hussong JW, Brown M, Perkins SL, et al. Comparison of DNA ploidy, histologic, and immunohistochemical findings with clinical outcome in inflammatory myofibroblastic tumors. Mod Pathol. 1999;12:279-286.
33. Mariñ o-Enŕquez A, Wang W-L, Roy A, et al. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK. Am J Surg Pathol. 2011; 35:135-144.
34. Kasashima S, Kobayashi M, Yamada M, et al. Myxoid endometrial stromal sarcoma of the uterus. Pathol Int. 2003;53:637-641.